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Goss KN, Cucci AR, Fisher AJ, Albrecht M, Frump A, Tur-
sunova R, Gao Y, Brown MB, Petrache I, Tepper RS, Ahlfeld SK,
Lahm T. Neonatal hyperoxic lung injury favorably alters adult right
ventricular remodeling response to chronic hypoxia exposure. Am J
Physiol Lung Cell Mol Physiol 308: L797–L806, 2015. First pub-
lished February 6, 2015; doi:10.1152/ajplung.00276.2014.—The de-
velopment of pulmonary hypertension (PH) requires multiple pulmo-
nary vascular insults, yet the role of early oxygen therapy as an initial
pulmonary vascular insult remains poorly defined. Here, we employ a
two-hit model of PH, utilizing postnatal hyperoxia followed by adult
hypoxia exposure, to evaluate the role of early hyperoxic lung injury
in the development of later PH. Sprague-Dawley pups were exposed
to 90% oxygen during postnatal days 0–4 or 0–10 or to room air. All
pups were then allowed to mature in room air. At 10 wk of age, a
subset of rats from each group was exposed to 2 wk of hypoxia
(Patm  362 mmHg). Physiological, structural, and biochemical end-
points were assessed at 12 wk. Prolonged (10 days) postnatal hyper-
oxia was independently associated with elevated right ventricular
(RV) systolic pressure, which worsened after hypoxia exposure later
in life. These findings were only partially explained by decreases in
lung microvascular density. Surprisingly, postnatal hyperoxia resulted
in robust RV hypertrophy and more preserved RV function and
exercise capacity following adult hypoxia compared with nonhyper-
oxic rats. Biochemically, RVs from animals exposed to postnatal
hyperoxia and adult hypoxia demonstrated increased capillarization
and a switch to a fetal gene pattern, suggesting an RV more adept to
handle adult hypoxia following postnatal hyperoxia exposure. We
concluded that, despite negative impacts on pulmonary artery pres-
sures, postnatal hyperoxia exposure may render a more adaptive RV
phenotype to tolerate late pulmonary vascular insults.
prematurity; right ventricular adaptation; pulmonary hypertension;
capillarization; atrial natriuretic peptide
PULMONARY ARTERIAL HYPERTENSION (PAH) is a devastating and
progressive pulmonary vasculopathy affecting all ages, ulti-
mately leading to right ventricular (RV) failure and death (14).
Although the etiology of PAH is multifactorial and incom-
pletely understood, the disease is considered to be the conse-
quence of a “two-hit” phenomenon, suggesting that multiple
factors must align for its development (43). Although influ-
ences such as genetic predisposition or hormonal abnormalities
have been identified as first hits, the potential contribution from
early abnormal alveolar and vascular development has not been
fully evaluated (4, 11).
A recent NHLBI Workshop on the Primary Prevention of
Chronic Lung Diseases identified a need to study “at-risk”
subjects for the development of PAH (5, 17). Along these lines,
a better understanding of early-life risk factors for development
of PAH is needed. Normally, the perinatal window represents
a critical time of lung development, where infants must tran-
sition from the simple saccular phase, with rapid expansion of
the distal airspaces to the mature alveolar phase, with bulk
alveolarization continuing into early childhood (20). Contem-
porary advancements in perinatal and neonatal care have low-
ered the limit of viability to 23 wk of gestation. Preterm
infants born before 28 wk of gestation have an immature
saccular lung that frequently is injured by exposure to life-
saving mechanical ventilation and a significant amount of
supplemental oxygen. Such noxious exposures disrupt normal
lung development and, as a result, the majority of extremely
preterm infants develop chronic lung disease (47). In its most
severe form, premature chronic lung disease manifests as
bronchopulmonary dysplasia (BPD), a disease characterized
primarily by impaired alveolar septation and decreased pulmo-
nary vascular density (10, 13, 24, 26, 52, 54). Despite contin-
ually improving ventilation strategies in the newborn period,
the increased survival of extremely preterm infants has in-
creased the burden of BPD (18, 49). This vast number of
premature infants continues to represent a group at risk for
pulmonary alveolar and vascular disease. In fact, prematurity
serves as an independent risk factor for the development of
neonatal pulmonary hypertension (PH), with roughly one in six
extremely preterm infants affected (9).
Evidence exists that arrested lung development attributable
to postnatal hyperoxia exposure, as is frequently seen with
prematurity, also affects the pulmonary vasculature later in life.
For example, in animal models, even brief exposure of the
developing lung to hyperoxia is associated with impaired
alveolarization and decreased pulmonary arterial density that
persist into adulthood (3, 15, 35, 56, 57). This is thought to be
attributable to subtle yet significant direct effects on the pul-
monary vasculature, suggesting that the pulmonary vascular
compartment is exquisitely sensitive to even brief insults dur-
ing development. Postnatal hyperoxia exposure and lung injury
also represent risk factors for later pulmonary vascular and RV
abnormalities in humans (31, 41). Although these studies
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suggest that postnatal hyperoxia exposure may represent a risk
factor for the development of PH later in life, no controlled
experimental studies have been performed that evaluate
whether and how postnatal hyperoxia affects the pulmonary
vasculature and RV upon exposure to a second insult later in
life.
Here, we utilize a novel two-hit model of PH to identify the
role of postnatal hyperoxic lung injury in independently and
synergistically promoting PH development later in life. Spe-
cifically, we investigated whether postnatal hyperoxia expo-
sure of the developing saccular lung predisposes rats to the
development of PH in adulthood following another common
pulmonary vascular insult, chronic hypoxia exposure. Hypoxia
was selected as a second hit because the high prevalence of
chronic lung diseases and sleep-disordered breathing in the
Western world would suggest that many prematurely born
individuals will be exposed to a relevant degree of hypoxia
later in life (7, 46, 53). We employed a comprehensive exper-
imental model to investigate the mechanisms by which varying
severities of early hyperoxic lung injury alter later responses to
hypoxia. We found that early hyperoxia exposure indeed wors-
ens pulmonary hypertensive responses later in life. However,
despite a more severe PH phenotype in this population, the
degree of RV adaptation to the increased afterload was more
preserved in animals undergoing early hyperoxia exposure. We
propose that early hyperoxia exposure allows for development
of adaptive mechanisms in the RV, thus contributing to an
improved tolerance of pulmonary vascular insults such as
hypoxia later in life.
MATERIALS AND METHODS
Animal models. Timed pregnant Sprague-Dawley dams (Harlan,
Indianapolis, IN) were allowed to deliver naturally at term in house.
Within 12 h of birth, male and female newborn rat pups were pooled
and randomized into one of three groups: 1) room air (RA), 2) 4-day
hyperoxia (4dO2), or 3) 10-day hyperoxia (10dO2; see Fig. 1 for
timeline). The two durations of hyperoxia exposure were used to
determine a dose response to postnatal hyperoxia, thus mimicking a
mild and a moderate-to-severe hyperoxic lung injury. The hyperoxia
groups were housed in standard cages within a 30”  20”  20”
polypropylene chamber with a clear acrylic door (BioSpherix, La-
cona, NY), as previously described (3). Oxygen concentration within
the chamber was maintained at or above a fraction of inspired oxygen
(FIO2) of 0.9 using of a continuous oxygen sensor. Dams were rotated
between RA and hyperoxia every 24–48 h to prevent oxygen toxicity.
For hyperoxia-exposed pups, dams and pups were removed from the
hyperoxia chamber after 4 or 10 days, respectively, and returned to
RA. All pups were then allowed to mature with their respective dams
and were weaned at 3 wk of age. At 10 wk of age, half of the rats from
each group were exposed to hypobaric hypoxia (Patm  362 mmHg;
equivalent to FIO2 of 0.1 at sea level) in a custom-made hypobaric
hypoxia chamber for an additional 2 wk as previously described (29).
Before initiation and after completion of 2 wk of hypoxia exposure, a
Fig. 1. Timeline of experimental exposures.
Brief hyperoxia (4-day, 4d) exposure is lim-
ited to the period of saccular lung develop-
ment, whereas prolonged hyperoxia (10-day,
10d) exposure includes injury well into the
bulk alveolarization phase. RA, room air; H,
hypoxia; GA, gestational age.
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subset of animals underwent exercise testing for determination of
maximal oxygen consumption (V˙ O2 max; see below). At the end of the
2-wk hypoxia exposure, animals underwent echocardiography, hemo-
dynamic assessments, and death. Animals were allowed access to
food and water ad libitum. All animal protocols were approved by the
Indiana University Institutional Animal Care and Use Committee.
Exercise testing. A subset of animals (n  6–7/group) began
treadmill familiarization at 8 wk of age, consisting of running 5 min
per day, 4 times per week for 2 wk at progressively faster pace (6–20
m/min) and incline (0–20°). This workload was selected to promote
familiarization to the treadmill without promoting a training effect
(30). At 10 and 12 wk of age (before the start and after the completion
of the 2-wk hypoxia exposure), animals performed exercise testing for
maximal oxygen consumption (V˙ O2 max). Metabolic measurements
were obtained using an indirect open-circuit calorimetric system
(Oxymax; Columbus Instruments, Columbus, OH). A gas analyzer
was calibrated using standardized gas mixtures (Praxair, Danbury,
CT), and baseline measurements were collected until V˙ O2 consump-
tion stabilized. A graded exercise test was performed, consisting of a
stepwise increase in treadmill speed and incline stages every 3 min as
follows: Stage I 10 m/min at 0°, Stage II 10 m/min at 5°, followed by
an increase by 5 m/min and 5° for each consecutive stage. The test
was terminated when V˙ O2 plateaued despite increasing workload or if
the rat was unable to maintain position on the treadmill belt despite
three consecutive shocks without recovery (8). All V˙ O2 max values are
expressed relative to body weight, and the highest achieved V˙ O2 was
recorded as the V˙ O2 max. To avoid acute effects of exercise testing on
echocardiographic, hemodynamic, and biochemical endpoints, at least
2 days were allowed between exercise testing and further assessments.
Echocardiography. Rats were lightly anesthetized with 1–2% iso-
flurane via nosecone to achieve adequate anesthesia with a heart rate
(HR) of 300–400 beats/min. Two-dimensional short-axis and long-
axis images were acquired using a high-resolution ultrasound system
(Vevo 2100; VisualSonics, Toronto, Ontario, Canada) equipped with
an 18–38-MHz scan probe. Long axis was used to measure the RV
outflow tract (RVOT) at the level of the tricuspid valve at mid systole.
Doppler was used to identify maximal velocities within the pulmonary
artery (PA) and record velocity time interval (VTI; calculated with
Vevo Analysis software on 3 consecutive cardiac cycles). Stroke
volume (SV) was determined using the formula SV VTI 3.142
(½RVOT)2, with cardiac output (CO) calculated by CO  SV  HR.
In a subset of animals, we assessed RV fractional shortening, mea-
sured by the change in end-diastolic to end-systolic diameter divided
by the end-diastolic diameter [(EDD  ESD)/EDD], as a measure of
cardiac contractility and performance (32). Rats were recovered from
anesthesia after determination of all echocardiographic endpoints.
Hemodynamic measurements. After a recovery period of at least 4
h following echocardiography, rats were anesthetized with isoflurane
(1–2%) and orally intubated. The left carotid artery and right internal
jugular vein were cannulated, and a 2F Millar catheter (Model
SPR-513; Millar Instruments, Houston, TX) was advanced into the
RV as previously described (29). RV systolic pressure (RVSP) and
mean arterial pressure (MAP) were recorded on 2% isoflurane with
supplemental oxygen, after verification of euthermia, normocapnea,
and normal pH. Once all hemodynamic endpoints were obtained,
animals were euthanized by exsanguination under anesthesia via the
arterial line, followed by immediate organ harvest.
RV hypertrophy. RV hypertrophy (RVH) was assessed by measur-
ing the Fulton index [weight of RV divided by weight of the left
ventricle plus septum; RV/(LV  S)]. Immediately after determina-
tion of RV and LV  S weights, the apex was placed in formalin for
later determination of capillarization; the rest of the RV was snap-
frozen for further biochemical analyses.
Pulmonary vascular remodeling. Lungs were flushed with normal
saline through a catheter inserted into the PA until clear return was
obtained from the left atrium. After excision of the right lung, the left
lung was then inflated via the trachea with 10% buffered formalin in
agarose under constant pressure (15 mmHg), removed from the
thoracic cavity, and embedded in paraffin. Verhoeff-Van Gieson
immunohistochemical staining was performed on lung sections, as
previously described (39). Pulmonary vascular wall area was then
determined in a blinded fashion by tracking the inner and outer border
of small- and medium-sized PAs (200 m diameter, 10 vessels per
animal, 20 objective) using Kodak software and by dividing the
measured area (pulmonary wall area) by the entire vessel area (entire
area encompassed by outer pulmonary arterial wall border, represent-
ing pulmonary wall area  lumen area). Pulmonary vascular remod-
eling was expressed as the ratio of the pulmonary wall area to the
entire vessel area. PAs were identified by proximity to terminal
bronchioles or alveolar ducts, as described previously (29). Images
were obtained using a Nikon Eclipse 80i microscope with camera and
NIS-Elements AR 3.0 software (Nikon Instruments, Melville, NY).
For pulmonary microvascular density, immunohistochemical stain-
ing with von Willebrand Factor [vWF; rabbit polyclonal anti-human
vWF (A0082), 1:2,500; Dako, Carpenteria, CA] was performed uti-
lizing the Vectastain Elite ABC kit (Vector Laboratories, Burlingame,
CA) with diaminobenzidine, as previously described (4). The number
of vWF-stained vessels 100 m in diameter per 10 field were
quantified and expressed as vessels per field. At least six nonoverlap-
ping fields per animal were analyzed from three transverse sections
obtained in nonbiased fashion from the left lung. Only fields consist-
ing of alveolar septa were used; fields containing large vessels or
conducting airways were avoided.
Determination of RV capillary density. RV capillary density was
assessed using immunofluorescence microscopy after incubation of
unstained RV sections with wheat germ agglutinin (WGA, a cell
membrane marker) conjugated to Oregon Green 488 (Life Technol-
ogies, Grand Island, NY) and 4=-6-diamidino-2-phenylindole (DAPI,
a nucleus marker; Life Technologies), as previously described (29).
Capillaries were identified by autofluorescence surrounded by WGA
staining. Capillaries and myocytes were manually counted in a
blinded fashion to give a capillary-to-myocyte ratio per high-power
field (40 objective). At least three high-power fields per animal were
analyzed.
Quantitative real-time RT-PCR. With the use of the Qiagen
RNeasy Fibrous Tissue kit (QIAGEN Sciences, Germantown, MD),
mRNA was carefully isolated from 25 mg of homogenized RV
tissue according to the manufacturer’s protocol. RNA (1 g) was
reverse transcribed into complimentary DNA (cDNA) using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA). cDNA was then diluted 10-fold, and real-time
RT-PCR was performed using TaqMan Gene Expression Master Mix
according to the manufacturer’s instructions (Invitrogen Life Tech-
nologies, Carlsbad, CA). TaqMan Assay Primers included the follow-
ing: 	-myosin heavy chain (MHC) (Myh6; Rn00691721_g1), 
-MHC
(Myh7; Rn01488777_g1), and atrial natriuretic peptide (ANP) (Nppa;
Rn00561661_m1); hypoxanthine phosphoribosyltransferase 1 was
used as a housekeeping gene (Hprt1, Rn01527840_m1). All PCR
reactions were performed using the Applied Biosystems 7500
Real-Time PCR System. Cycling parameters were as follows: 50°C
for 2 min, 95°C for 10 min, and 95°C for 15 s followed by 60°C
for 1 min for 40 cycles. Hprt1 was used as the reference gene, and
all gene expression results were expressed as mean fold change
from controls  SE.
Data and statistical analysis. Results are expressed as means SE.
Where individual points are shown, results represent individual ani-
mals with horizontal lines depicting means and error bars representing
SE. Experimental groups were compared by one-way ANOVA, using
Tukey’s multiple-comparison posttest analysis to determine between
group differences (GraphPad Prism 5; GraphPad, La Jolla, CA).
Grouped data sets were analyzed with two-way ANOVA. Differences
at 	-level of 0.05 (P  0.05) were considered statistically significant.
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Postnatal hyperoxia worsens PH in adulthood. We first
evaluated the effects of hyperoxia and hypoxia on RVSP.
Whereas brief (4-day) hyperoxia exposure alone did not alter
RVSP, animals exposed to prolonged (10-day) hyperoxia had
evidence of persistent PH at 12 wk of age (Fig. 2A). However,
these elevations in RVSP were not as robust as those induced
by chronic hypoxia exposure (Fig. 2A). As we hypothesized,
hypoxia-induced increases in RVSP were most pronounced in
animals exposed to postnatal hyperoxia. Whereas RVSP
trended higher in 4dO2-H vs. RA-H, it reached statistical
significance in the 10dO2-H vs. RA-H group (Fig. 2A), indi-
cating that postnatal hyperoxia exposure potentiates pulmonary
hypertensive responses later in life by more than 30%.
We next evaluated the two-hit effects on RVH, as an
established parameter reflecting changes in PA pressure and
PA remodeling (45). Rats exposed to either brief or prolonged
postnatal hyperoxia alone had no evidence of RVH (Fig. 2B).
Following adult hypoxia exposure, all animals developed RVH
consistent with a robust hypoxic PH phenotype (Fig. 2B).
Importantly, both 4-day and 10-day hyperoxia exposure fol-
lowed by adult hypoxia were associated with exaggerated
RVH, suggesting that postnatal hyperoxia exposure alters RV
responses to chronic hypoxia later in life. LV mass (expressed
as LV S weight indexed to body weight) was not affected by
hyperoxia or hypoxia alone compared with RA controls (Fig.
2C). Interestingly, there was a significant increase in LV mass
among animals exposed to 10 days of postnatal hyperoxia
followed by adult hypoxia (Fig. 2C). Whereas postnatal hy-
peroxia did not significantly affect systemic pressures later in
life, hypoxia exposure was associated with an increase in
MAP, independent of early hyperoxia exposure (Fig. 2D).
Taken together, these data suggest that postnatal hyperoxia
exposure is associated with development of more severe PH
upon hypoxia exposure later in life.
Postnatal hyperoxia-induced effects on PA pressures are not
associated with increased vascular remodeling in the lung. We
hypothesized that the increase in RVSP in the prolonged
hyperoxia model was attributable to either elevated pulmonary
vascular resistance created by hypoxia-induced PA remodeling
with increased muscularization or to rarefaction of pulmonary
microvessels as a direct result of the early hyperoxia exposure.
As such, we analyzed the degree of small- and medium-sized PA
muscularization as a function of PA wall area. As expected, all
animals exposed to adult hypoxia developed increased PA mus-
cularization, consistent with a hypoxic PH phenotype (Fig. 3A).
However, there was no additive effect of postnatal hyperoxia on
the degree of PA muscularization to account for the significant
increases in RVSP among this group.
To assess for loss of pulmonary microvasculature, we ana-
lyzed the microvascular density per high-power field. Animals
exposed to prolonged neonatal hyperoxia had a small but
statistically significant decrease in pulmonary microvessel den-
sity (Fig. 3B). However, pulmonary microvessel rarefaction
was not exacerbated further by postnatal hypoxia exposure,
and no significant differences were seen between RA-H,
4dO2-H, or 10dO2-H animals. Furthermore, we did not find a
significant increase in perivascular accumulation of inflamma-
tory cells in any of the hypoxia-exposed groups, nor did we
find any evidence of neointima formation or thrombotic occlu-
Fig. 2. Postnatal hyperoxia exposure leads to
increased right ventricular systolic pressure
(RVSP) and increased RV hypertrophy (RVH)
after adult hypoxia exposure. Postnatal hyper-
oxia (FIO2  0.9) exposure occurred for the first
4 or 10 days of life, respectively. Hypoxia
exposure (Patm 362 mmHg for 2 wk) occurred
from week 10 to week 12. All end points were
measured at 12 wk. A: pulmonary hypertension
(PH) assessed by measurement of RVSP. PH
develops after hypoxia exposure but is most
severe in animals exposed to prolonged (10-
day) postnatal hyperoxia. B: RVH assessment
by Fulton index [weight of RV divided by
weight of the left ventricle plus septum; RV/
(LV  S)] following postnatal hyperoxia and
adult hypoxia exposures. Note exaggerated
RVH in animals exposed to postnatal hyperoxia
and hypoxia. C: assessment of LV hypertrophy
(reported as LV weight indexed to body weight)
demonstrates similar LV hypertrophy among
groups. D: mean arterial pressures (MAP) in-
crease following hypoxia exposure but are not
affected by hyperoxia exposure. Group labels are
as outlined in Fig. 1. Points represent individual
animals, and error bars represent means  SE.
Analysis by 1-way ANOVA; *P  0.05, **P 
0.01, ***P  0.001 compared with RA control
(RA-RA); #P 0.05, ##P 0.01, ###P 0.001
compared with RA-hypoxia (RA-H).
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sive disease to account for the significant increases in RVSP
(data not shown). Thus the underlying mechanism of the
increased PA pressures in postnatal hyperoxia-exposed animals
may only be partially explained by increased rarefaction of
pulmonary microvessels resulting from the initial hyperoxic
exposure.
Postnatal hyperoxia is associated with more preserved RV
function and exercise capacity following adult hypoxia
exposure. To assess RV adaptation to the increased pulmonary
vascular pressures, we measured CO via echocardiography.
Intriguingly, both short (4 days) and especially prolonged (10
days) postnatal hyperoxia led to more preserved average CO
following adult hypoxia compared with RA-H animals (Fig. 4A).
Although there was a significant degree of heterogeneity in the
10dO2-H group, this suggests better overall RV adaptation to
adult hypoxia exposure following early hyperoxia. The in-
crease in CO was driven entirely by increases in SV, as HR
remained similar between groups (data not shown). To corrob-
orate these data indicating increased CO in the 10dO2-H group,
we measured RV fractional shortening as a marker of RV
contractility in a subset of RA-H and 10dO2-H (32). As
expected, the 10dO2-H animals exhibited a significant increase
in fractional shortening compared with RA-H animals, again
indicating preserved cardiac function in this group (Fig. 4B).
To further evaluate the functional effects of these findings,
we performed exercise testing, demonstrating preserved exer-
cise capacity after hypoxia exposure in 10dO2-H animals,
whereas the RA-H and 4dO2-H animals exhibited an expected
decline in V˙ O2 max after hypoxia exposure (Fig. 4C). Pre- and
posthypoxia exposure weights were similar among all groups.
Together, these data suggest a more adaptive RV phenotype
following prolonged postnatal hyperoxia exposure.
Postnatal hyperoxia is associated with a more adapted RV
phenotype. On the basis of our findings of more preserved RV
function and exercise capacity in the 10dO2-H group, we next
sought to determine morphological and molecular correlates
consistent with increased RV adaptation. Because of the lack
of RV functional changes in the postnatal hyperoxia alone
groups (Fig. 4), we focused these investigations on the hyper-
oxia-hypoxia-exposed groups. Because increases in RV capil-
Fig. 3. Increased RVSP and increased RV hypertrophy in hyperoxia-hypoxia groups cannot be explained by increased pulmonary artery (PA) muscularization
or decreased vascular density. A: Verhoff-van Gieson staining of lung demonstrates increased PA muscularization following hypoxia exposure with no additional
effect of postnatal hyperoxia. PA muscularization was determined in a blinded fashion by dividing the measured pulmonary wall area by the entire vessel area.
Representative images taken at 20. Size bars  50 m. Note hypoxia-induced increase in PA wall thickness (indicated by arrowheads). B: von Willebrand
factor staining demonstrates decreased pulmonary vascular density following hypoxia exposure (vessels marked by arrowheads). Note that animals exposed to
prolonged neonatal hyperoxia had a small but statistically significant decrease in pulmonary microvessel density although pulmonary microvessel rarefaction was
not exacerbated further by postnatal hypoxia exposure. Representative images taken at 10. Size bars  50 m. Points represent individual animals, and error
bars represent means  SE. Analysis by 1-way ANOVA. *P  0.05 compared with RA-RA.
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lary density have previously been shown to correlate with
improved RV adaptation and function, we first evaluated this
parameter (42). Indeed, the RV capillary density, expressed as
a ratio of capillaries to myocytes per high-power field, was
increased in animals exposed to postnatal hyperoxia, being
especially pronounced in the 4dO2-H group, which had an
almost 50% increase in capillarization compared with RA
controls (Fig. 5).
We next evaluated whether postnatal hyperoxia exposure
results in a magnified switch back to a fetal gene profile in the
RV, which could serve as a potential adaptive mechanism to
better withstand hypoxic events (38, 40, 48). Reversion to a
Fig. 4. Postnatal hyperoxia is associated with more preserved RV function and exercise capacity upon hypoxia exposure. A: cardiac output (CO) measured by
echocardiography (ECHO) demonstrates cardiac dysfunction following hypoxia, with relative preservation of CO in animals exposed to prolonged postnatal
hyperoxia. B: factional shortening, measured by the change in end-diastolic to end-systolic diameter over the end-diastolic diameter [(EDD  ESD)/EDD], was
measured in a subset of hypoxia-exposed animals, again demonstrating significantly improved cardiac function in 10dO2-H animals compared with RA-H.
C: maximal exercise capacity declines as expected after adult hypoxia exposure, yet animals with prolonged postnatal hyperoxia exposure demonstrate no
significant decrease in exercise capacity following adult hypoxia. Points represent individual animals, and error bars represent means  SE. Analysis by 1-way
ANOVA; **P  0.01 compared with RA-RA; ##P  0.01 compared with RA-H; ¤P  0.05 for pre- and posthypoxia comparison.
Fig. 5. Postnatal hyperoxia is associated with increased RV capillary density. RV capillary density was assessed by immunofluorescence. Wheat germ agglutinin
(WGA) antibody was used to stain cell membranes (green), whereas nuclei were stained with 4=-6-diamidino-2-phenylindole (DAPI) (blue). Cardiomyocytes are
identified by typical shape and myoglobin autofluorescence surrounded by WGA staining (arrows); capillaries are identified by size and autofluorescence
surrounded by WGA staining (arrowheads). Cardiomyocytes and capillaries were quantified in a blinded fashion, and capillary-to-myocyte ratios were
determined. Left: capillary/myocyte ratios after analysis. Right: representative images at 40. Note increased capillarization following brief hyperoxia-hypoxia
exposure. Size bars  25 m. Points represent individual animals, and error bars represent means  SE. Analysis by 1-way ANOVA. *P  0.05 compared with
RA-RA. HPF, high-power field.
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fetal gene profile is well described in other models of PH and
is associated with improved RV adaptation to afterload stress
(40). This gene profile is characterized by decreased 	-MHC
expression and increased expression of 
-MHC and ANP (33,
36, 48), a signature recapitulated in the RV of all animals
exposed to adult hypoxia (Fig. 6, A and B). Of these, the
expression levels of ANP were significantly augmented in
hypoxic animals exposed to postnatal hyperoxia (Fig. 6C),
suggesting an exaggerated shift to a fetal phenotype. Taken
together, the data in Figs. 5 and 6 suggest a more adapted RV
phenotype in hypoxic rats previously exposed to postnatal
hyperoxia.
DISCUSSION
This study represents one of the most extensive functional
evaluations examining the role of postnatal hyperoxia exposure
in promoting adult PH, both independently and synergistically
with adult hypoxia in a two-hit model of disease. We show that
postnatal hyperoxia exaggerates pulmonary hypertensive re-
sponses upon hypoxia exposure later in life. Of note, these
findings cannot be explained by exaggerated hypoxia-induced
PA remodeling, neointimal formation, thrombotic lesions, or
increased inflammatory deposits and are likely only partially
explained by a decrease in lung vascular density. Interestingly,
and somewhat unexpectedly, RV function and exercise capac-
ity following hypoxia exposure were more preserved in the
10-day hyperoxia group, suggesting that prolonged postnatal
hyperoxia exposure is associated with a more adaptive RV
phenotype following hypoxia challenge later in life. Indeed, the
results of our concomitant investigations of biochemical and
structural endpoints in the RV suggest that postnatal hyperoxia
is associated with a more adaptive RV phenotype to late
pulmonary vascular insults.
In this rat model, brief hyperoxia alone did not result in late
RVH or PH, whereas prolonged hyperoxia caused mild PH in
adulthood (albeit without significant RVH). However, when
combined with late hypoxia exposure, both brief and prolonged
hyperoxia exposure caused robust RVH, but only prolonged
hyperoxia significantly augmented RVSP. These findings indi-
cate potentially differential effects of early hyperoxia exposure
on the RV vs. the pulmonary vasculature.
The cause of the elevated RVSP in the animals exposed to
prolonged hyperoxia may be partially explained by increased
pulmonary resistance resulting from decreased pulmonary mi-
crovascular density. Previous studies have shown a decrease in
pulmonary vascular density both in the immediate postnatal
period and in the adult lung following postnatal hyperoxia
exposure (6, 28, 49, 50, 57). Importantly, these effects are
likely dependent on the duration and severity of hyperoxia
exposure as well as the time point at which the pulmonary
vascular density is evaluated (55). It is also possible that the
elevations in RVSP in the prolonged hyperoxia-hypoxia group
are the result of increased hypoxic pulmonary vasoconstriction
although this was not assessed in this study and represents a
potential area for future investigation. Such a potential for
increased susceptibility to hypoxic pulmonary vasoconstriction
is suggested by a study of adult subjects with a history of
persistent PH of the newborn, who demonstrated a significant
increase in RVSP by echocardiography at altitude compared
with normal age-matched controls (41). It is also possible,
given the improved CO noted by echocardiography, that the
increased PA pressures in the hyperoxia-hypoxia group are a
reflection of improved cardiac contractility and SV (12). On-
going studies investigating hypoxic pulmonary vasoconstric-
tion, cardiac contractility, and measures of PA-RV coupling in
our model will be able to dissect the relative contribution of
these factors.
Importantly, our data reinforce the notion that the presence
of RVH alone is insufficient to discern between an adaptive vs.
maladaptive cardiac response. By including physiological pa-
rameters in our assessment, we came to the surprising conclu-
sion that postnatal hyperoxia exposure was associated with
preserved CO and exercise capacity following hypoxia. This
suggests that early hyperoxia exposure may have a priming
effect on the RV, altering the RV compensatory response to
later pulmonary vascular insults such as hypoxia. Cardiac
preconditioning effects are well described in ischemia reper-
fusion models, but these effects typically last only 3 to 4 days
at most (44, 58). Such long-term priming from postnatal events
has not previously been described but may be most reminiscent
of an Eisenmenger’s phenomenon. In Eisenmenger’s syn-
drome, CO is maintained despite severe elevations in pulmo-
Fig. 6. Postnatal hyperoxia is associated with a more robust fetal gene expression pattern. End points were determined by real-time RT-PCR of RV homogenates.
Hypoxia induces a decrease in 	-myosin heavy chain (	-MHC, A) and increase in 
-MHC (B) gene expression consistent with a fetal gene profile. Atrial
natriuretic peptide (ANP) gene expression also increases after hypoxia exposure consistent with a fetal gene profile and is potentiated in animals with a history
of early hyperoxia exposure (C). Points represent individual animals, and error bars represent means SE. Analysis by 1-way ANOVA. *P 0.05, **P 0.01,
***P  0.001 compared with RA-RA.
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nary vascular resistance and pressure, believed to be secondary
to a continuous physiological RV priming from birth (19, 23,
25). Unfortunately, the mechanisms by which Eisenmenger’s
hearts remodel and adapt remain to be elucidated. Our studies
may thus prove to be beneficial in understanding the priming
effect that occurs in the Eisenmenger’s RV as well as during
and after early hyperoxia exposure.
We hypothesized that an earlier or exaggerated switch to a
fetal gene pattern, with its relative preference for a hypoxic
environment, could promote improved tolerance of adult hyp-
oxia and account for the preserved CO and V˙ O2 max. Although
alterations in 	-MHC and 
-MHC gene expression were sim-
ilar among all hypoxia-exposed animals, even minor degrees of
isoform switching, which may have been undetected in our
study, could significantly impact contractility and tolerance of
hypoxia (22, 34). The additive increments in ANP expression
induced in the two-hit model are nevertheless consistent with
development of a magnified fetal gene expression in the RV
and may suggest a role for increased neurohormonal activation
in these animals. Overall, the exact mechanism of such adap-
tive responses is unclear and merits further investigation and
corroboration in alternative PAH models, such as the Sugen-
hypoxia model. One potential modifier of improved RV func-
tion in our model may be improved mitochondrial biogenesis,
and studies of mitochondrial function are currently ongoing in
our laboratory. Lastly, because V˙ O2 max is also affected by
skeletal muscle function, we are investigating effects of peri-
natal hyperoxia and hypoxia on skeletal muscle function.
A potential limitation of our study is that the detection of
several end points may be improved with more sensitive
techniques, such as stereological assessment of capillary den-
sity or the use of RV pressure-volume conductance catheters,
to gain further insight into mechanisms of increased PA pres-
sures in the two-hit model. In addition, potential influences of
sex on our results cannot be ruled out; however, although we
included both male and female animals in our studies, numbers
were too small for robust investigations of sex differences.
Nevertheless, the major strength of our model is that it allows
for a detailed physiological investigation of the effects of
varying durations of postnatal hyperoxia and tolerance of later
pulmonary vascular injury in the form of adult hypoxia expo-
sure. Importantly, this novel two-hit animal model demon-
strates that postnatal hyperoxia alone can result in long-term
increases in PA pressures, identifying a notable risk factor that
may help identify new populations at risk for developing PH
(5, 16). Furthermore, we have identified a new paradigm in
which the RV can actually be primed by early hyperoxia
exposure to better tolerate later pulmonary vascular insults.
There is significant potential for clinical application of our
study findings. We have demonstrated a clear association
between early hyperoxia exposure and later development of
PH. Given the high prevalence of premature deliveries and the
extremely high incidence of oxygen exposure in premature
infants, this may suggest a need for increased screening for PH
in adults with a history of extreme prematurity. One limitation
is that our model is not specifically a model of prematurity and,
therefore, does not account for the totality of effects hyperoxia
has on the developing cardiopulmonary system (37). However,
neonatal rats are born with a simple saccular lung similar to
that of extremely preterm infants (27), and early exposure of
the neonatal rodent lung to hyperoxia reliably inhibits alveolar
septal and microvascular development to recapitulate the hall-
marks of human BPD (1, 2, 51). Thus our model remains
highly relevant to the neonatal condition. Importantly, if these
patients truly have improved adaptive properties of the RV,
development of PH may go undetected for longer periods of
time. Interestingly, a recent study published by Lewandowski
et al. (31) demonstrated that increasing severity of prematurity
was associated with increasing RV mass and an increased risk
for RV dysfunction. Unfortunately, this study did not address
the severity of concomitant pulmonary vascular disease, which
could be expected to have a significant effect on RV function.
However, that study as well as ours underscores the need for
increased recognition of pulmonary vascular dysfunction in
adults with a history of prematurity.
In summary, we found that postnatal hyperoxia exposure
induces adult PH and potentiates the pulmonary vascular re-
sponse to hypoxia. We also identified a potential cardiac
priming effect of early hyperoxia exposure, resulting in signif-
icant resiliency and improved RV tolerance of late hypoxia-
induced pulmonary vascular insults. Importantly, given that
RV function is what ultimately drives morbidity and mortality
in pulmonary vascular disease, improvement in the ability of
the RV to compensate for pulmonary insults is critical to
survival (14, 21). Further identification of the mechanisms by
which these RVs may compensate could allow for targeted and
RV-specific therapies to improve compensatory mechanisms in
pediatric and adult forms of PH.
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